💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch
User | Tweets |
---|---|
@newsfilterio | 6 |
@Tickeron | 5 |
@Gambiste1 | 4 |
@mediasentiment | 3 |
@StckPro | 3 |
![]() |
@jonny_mr $CLLS Top analyst target price for next week.>.?? https://t.co/DD36TS2zqC 4:01am |
![]() |
@stockalart05 $CLLS Top analyst target price for next week>>>?? https://t.co/s96qBzwVJY January 26th 2023, 4:01pm |
![]() |
@stockalart05 $CLLS *Top analyst target price for next week-->? https://t.co/s96qBzwVJY January 25th 2023, 6:01pm |
![]() |
@LondonJ46249603 $CLLS Top analyst target price for next week? https://t.co/FXedLd42Ff January 25th 2023, 2:01pm |
![]() |
@DavidPe05712916 $CLLS *ALL THESE LEVELS POSTED AHEAD OF TIME BEFORE THE MARKET OPENED ??? https://t.co/uUixiD3PVH January 25th 2023, 6:01am |
![]() |
@Jhum78281941 $CLLS *ALL THESE LEVELS POSTED AHEAD OF TIME BEFORE THE MARKET OPENED ??? https://t.co/HxOG3AuY0X January 25th 2023, 4:01am |
![]() |
@PeterHa18329727 $CLLS *ALL THESE LEVELS POSTED AHEAD OF TIME BEFORE THE MARKET OPENED.??? https://t.co/GrrtWbve1m January 25th 2023, 2:01am |
![]() |
@VistaPResearch RT @VistaPResearch: Cellectis $CLLS Amends $20M Convertible Note Under Collaboration Agreement w/ its #Partner #CytoviaTherapeutics https:/… January 24th 2023, 7:01pm |
![]() |
@VistaPResearch Cellectis $CLLS Amends $20M Convertible Note Under Collaboration Agreement w/ its #Partner #CytoviaTherapeutics… https://t.co/DQEevJofDF January 24th 2023, 6:01pm |
![]() |
@Shirley56971602 $CLLS *ALL THESE LEVELS POSTED AHEAD OF TIME BEFORE THE MARKET OPENED.??? https://t.co/xodjT4uhne January 24th 2023, 4:01pm |
![]() |
@Madelei30790030 $CLLS *ALL THESE LEVELS POSTED AHEAD OF TIME BEFORE THE MARKET OPENED.??? https://t.co/vHRAPIfurZ January 24th 2023, 2:01pm |
![]() |
@Eva077777 $CLLS Top analyst target price for next week? https://t.co/oSMOYcN6HB January 24th 2023, 12:01pm |
![]() |
@Deirdre27476705 $CLLS *ALL THESE LEVELS POSTED AHEAD OF TIME BEFORE THE MARKET OPENED.??? https://t.co/EwcB3kKvBm January 24th 2023, 12:01pm |
![]() |
@MariaWi64927347 $CLLS *ALL THESE LEVELS POSTED AHEAD OF TIME BEFORE THE MARKET OPENED..! https://t.co/AMj3zB4yrF January 24th 2023, 5:01am |
![]() |
@Jennife16674918 $CLLS *ALL THESE LEVELS POSTED AHEAD OF TIME BEFORE THE MARKET OPENED ??? https://t.co/7atCxxqOhT January 24th 2023, 4:01am |
![]() |
@Gambiste1 RT @Saif_trading: $CLLS ?? https://t.co/8cfQgeb3Vc https://t.co/UDBUCnxlgC January 24th 2023, 1:01am |
![]() |
@RoseQue91610166 RT @MarcJacksonLA: $CLLS Cellectis Amends $20 Million Convertible Note Under Collaboration Agreement with its Partner Cytovia Therapeutics… January 24th 2023, 12:01am |
![]() |
@MarcJacksonLA $CLLS Cellectis Amends $20 Million Convertible Note Under Collaboration Agreement with its Partner Cytovia Therapeu… https://t.co/YTnV4Q3IXI January 23rd 2023, 10:01pm |
![]() |
@EmilyEv66750646 $CLLS Top analyst target price for next week? https://t.co/xlsSaNnRSF January 23rd 2023, 9:01pm |
![]() |
@johnfheerdinkjr RT @johnfheerdinkjr: #BabyCamel #Camel #nature #amazing #MondayMotivation #stocks #trading #TradingView #SwingTrading $BRQS +4.47% $CLLS… January 23rd 2023, 8:01pm |
![]() |
@Gabriel695825 $CLLS Top analyst target price for next week? https://t.co/W4N8W6GBuk January 23rd 2023, 8:01pm |
![]() |
@Ainvest_Wire Cellectis up 11% after Cytovia note revision $CLLS #Ainvest #Ainvest_Wire #market #liveanalysis #investors View mo… https://t.co/Rxf6TveQ0p January 23rd 2023, 6:01pm |
![]() |
@giaparson785 $CLLS Top analyst target price for next week? https://t.co/Y2LzIXQxjM January 23rd 2023, 6:01pm |
![]() |
@Deirdre27476705 $CLLS *ALL THESE LEVELS POSTED AHEAD OF TIME BEFORE THE MARKET OPENED ??? https://t.co/EwcB3kKvBm January 23rd 2023, 6:01pm |
![]() |
@samin87952302 $CLLS Top analyst target price for next week? https://t.co/zqxD3csY0x January 23rd 2023, 6:01pm |
![]() |
@TamiLyo83158337 $CLLS *ALL THESE LEVELS POSTED AHEAD OF TIME BEFORE THE MARKET OPENED ??? https://t.co/dbXkVd5WnO January 23rd 2023, 4:01pm |
![]() |
@Saif_trading $CLLS ?? https://t.co/8cfQgeb3Vc https://t.co/UDBUCnxlgC January 23rd 2023, 2:01pm |
![]() |
@AlertTrade RT @Briefingcom: $CLLS +10.1% https://t.co/V8lRgRnqy7 January 23rd 2023, 2:01pm |
![]() |
@Briefingcom $CLLS +10.1% https://t.co/V8lRgRnqy7 January 23rd 2023, 2:01pm |
![]() |
@AlertTrade RT @Briefingcom: $CLLS: Cellectis amends $20 mln convertible note under collaboration agreement with its partner Cytovia Therapeutics https… January 23rd 2023, 1:01pm |
![]() |
@Briefingcom $CLLS: Cellectis amends $20 mln convertible note under collaboration agreement with its partner Cytovia Therapeutics https://t.co/k0vFtnMi7u January 23rd 2023, 1:01pm |
![]() |
@JordonM92747470 $CLLS Top analyst target price for next week? https://t.co/gp1kXX2prr January 23rd 2023, 1:01pm |
![]() |
@Rose30963993 $CLLS *ALL THESE LEVELS POSTED AHEAD OF TIME BEFORE THE MARKET OPENED ??? https://t.co/XqisL2cDXi January 23rd 2023, 11:01am |
![]() |
@astockwatch1 $CLLS Cellectis Amends $20 Million Convertible Note Under Collaboration Agreement with its Partner Cytovia Therapeu… https://t.co/ADP8rgWG6v January 23rd 2023, 11:01am |
![]() |
@Tickeron What stocks might make more money? Compare $ALLO vs. $CLLS. #AllogeneTherapeutics https://t.co/84wL4H5fvt https://t.co/7wp8Dvi8bo January 23rd 2023, 3:01am |
![]() |
@Beeken_health $CLLS - Cellectis Amends $20 Million Convertible Note Under Collaboration Agreement with its Partner Cytovia Therap… https://t.co/g4KnQlKVjU January 21st 2023, 8:01pm |
![]() |
@Beeken_health $CLLS - Cellectis Amends $20 Million Convertible Note Under Collaboration Agreement with its Partner Cytovia Therap… https://t.co/U5dix6G5lr January 21st 2023, 2:01pm |
![]() |
@newsfilterio Form 6-K (report of foreign issuer [rules 13a-16 and 15d-16]) filed with the SEC $CLLS https://t.co/iETs0OeJnz January 21st 2023, 1:01am |
![]() |
@StckPro $CLLS NEW ARTICLE : Cellectis Amends $20 Million Convertible Note Under Collaboration Agreement with its Partner Cy… https://t.co/wdlHdO2fQg January 20th 2023, 10:01pm |
![]() |
@StckPro $CLLS NEW ARTICLE : Cellectis Amends $20 Million Convertible Note Under Collaboration Agreement with its Partner Cy… https://t.co/pVwkIXHbnz January 20th 2023, 10:01pm |
![]() |
@StckPro $CLLS NEW ARTICLE : Cellectis Amends $20 Million Convertible Note Under Collaboration Agreement with its Partner Cy… https://t.co/vrx5vtBRJT January 20th 2023, 9:01pm |
![]() |
@quantisnow $CLLS ? SEC Form 6-K filed by Cellectis S.A. https://t.co/tanZz1KXE3 45 seconds delayed. January 20th 2023, 9:01pm |
![]() |
@investor_feed $CLLS 6-K Cellectis (20 Jan, 4:36pm) ? Cellectis Amends $20 Million Convertible Note Under Collaboration Agree… https://t.co/Ex1JUa4mDQ January 20th 2023, 9:01pm |
![]() |
@Tradesense_me $CLLS ? ? Press Release Cellectis Amends $20 Million Convertible Note Under Collaboration Agreement with its Partn… https://t.co/uMp6yOraOw January 20th 2023, 9:01pm |
![]() |
@StockNewsBot2 $CLLS Cellectis Amends $20 Million Convertible Note Under Collaboration Agreement with its Partner Cytovia Therapeu… https://t.co/8nXf3alSbs January 20th 2023, 9:01pm |
![]() |
@quantisnow $CLLS ? Cellectis Amends $20 Million Convertible Note Under Collaboration Agreement with its Partner Cytovia Therap… https://t.co/PDGpQBn8Yx January 20th 2023, 9:01pm |
![]() |
@stock_titan $CLLS Cellectis Amends $20 Million Convertible Note Under Collaboration Agreement with its Partner Cytovia Therapeu… https://t.co/BQw3pdM04N January 20th 2023, 9:01pm |
![]() |
@mediasentiment $CLLS new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 421 January 20th 2023, 11:01am |
![]() |
@mediasentiment $CLLS new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 420 January 20th 2023, 11:01am |
![]() |
@Tradesense_me $CLLS ? ? Target Price $CLLS JMP Securities analyst Silvan Tuerkcan maintains Cellectis with a Market Outperform a… https://t.co/ET6yLdwp4D January 20th 2023, 8:01am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2023. All rights reserved.